Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S., Bociek, R. Gregory, Sawas, Ahmed, Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M., Crosswell, Howland E., Islas-Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero-Torres, Andres, Vose, Julie, O'Connor, Owen A., Josephson, Neil, Wang, Yinghui, Advani, Ranjana
Published in Blood (05.07.2018)
Published in Blood (05.07.2018)
Get full text
Journal Article
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Advani, Ranjana, Flinn, Ian, Popplewell, Leslie, Forero, Andres, Bartlett, Nancy L, Ghosh, Nilanjan, Kline, Justin, Roschewski, Mark, LaCasce, Ann, Collins, Graham P, Tran, Thu, Lynn, Judith, Chen, James Y, Volkmer, Jens-Peter, Agoram, Balaji, Huang, Jie, Majeti, Ravindra, Weissman, Irving L, Takimoto, Chris H, Chao, Mark P, Smith, Sonali M
Published in The New England journal of medicine (01.11.2018)
Published in The New England journal of medicine (01.11.2018)
Get full text
Journal Article
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
Advani, Ranjana H., Moskowitz, Alison J., Bartlett, Nancy L., Vose, Julie M., Ramchandren, Radhakrishnan, Feldman, Tatyana A., LaCasce, Ann S., Christian, Beth A., Ansell, Stephen M., Moskowitz, Craig H., Brown, Lisa, Zhang, Chiyu, Taft, David, Ansari, Sahar, Sacchi, Mariana, Ho, Linda, Herrera, Alex F.
Published in Blood (12.08.2021)
Published in Blood (12.08.2021)
Get full text
Journal Article
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Herrera, Alex F., Moskowitz, Alison J., Bartlett, Nancy L., Vose, Julie M., Ramchandren, Radhakrishnan, Feldman, Tatyana A., LaCasce, Ann S., Ansell, Stephen M., Moskowitz, Craig H., Fenton, Keenan, Ogden, Carol Anne, Taft, David, Zhang, Qu, Kato, Kazunobu, Campbell, Mary, Advani, Ranjana H.
Published in Blood (15.03.2018)
Published in Blood (15.03.2018)
Get full text
Journal Article
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Gibson, Christopher J, Lindsley, R Coleman, Tchekmedyian, Vatche, Mar, Brenton G, Shi, Jiantao, Jaiswal, Siddhartha, Bosworth, Alysia, Francisco, Liton, He, Jianbo, Bansal, Anita, Morgan, Elizabeth A, Lacasce, Ann S, Freedman, Arnold S, Fisher, David C, Jacobsen, Eric, Armand, Philippe, Alyea, Edwin P, Koreth, John, Ho, Vincent, Soiffer, Robert J, Antin, Joseph H, Ritz, Jerome, Nikiforow, Sarah, Forman, Stephen J, Michor, Franziska, Neuberg, Donna, Bhatia, Ravi, Bhatia, Smita, Ebert, Benjamin L
Published in Journal of clinical oncology (10.05.2017)
Published in Journal of clinical oncology (10.05.2017)
Get full text
Journal Article
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zhou, Zheng, Sehn, Laurie H., Rademaker, Alfred W., Gordon, Leo I., LaCasce, Ann S., Crosby-Thompson, Allison, Vanderplas, Ann, Zelenetz, Andrew D., Abel, Gregory A., Rodriguez, Maria A., Nademanee, Auayporn, Kaminski, Mark S., Czuczman, Myron S., Millenson, Michael, Niland, Joyce, Gascoyne, Randy D., Connors, Joseph M., Friedberg, Jonathan W., Winter, Jane N.
Published in Blood (06.02.2014)
Published in Blood (06.02.2014)
Get full text
Journal Article
Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse events
Singer, Sean, Tan, Sally Y., Dewan, Anna K., Davids, Matthew, LaCasce, Ann S., Treon, Steven P., LeBoeuf, Nicole R.
Published in Journal of the American Academy of Dermatology (01.06.2023)
Published in Journal of the American Academy of Dermatology (01.06.2023)
Get full text
Journal Article
PI3K inhibitors in haematological malignancies
Brown, Jennifer R, Danilov, Alexey V, LaCasce, Ann S, Davids, Matthew S
Published in The lancet oncology (01.08.2022)
Published in The lancet oncology (01.08.2022)
Get full text
Journal Article
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wilson, Wyndham H, Prof, O'Connor, Owen A, Prof, Czuczman, Myron S, Prof, LaCasce, Ann S, MD, Gerecitano, John F, MD, Leonard, John P, Prof, Tulpule, Anil, MD, Dunleavy, Kieron, MD, Xiong, Hao, PhD, Chiu, Yi-Lin, PhD, Cui, Yue, PhD, Busman, Todd, MS, Elmore, Steven W, PhD, Rosenberg, Saul H, PhD, Krivoshik, Andrew P, MD, Enschede, Sari H, MD, Humerickhouse, Rod A, MD
Published in The lancet oncology (01.12.2010)
Published in The lancet oncology (01.12.2010)
Get full text
Journal Article
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
Davids, Matthew S, Lampson, Benjamin L, Tyekucheva, Svitlana, Wang, Zixu, Lowney, Jessica C, Pazienza, Samantha, Montegaard, Josie, Patterson, Victoria, Weinstock, Matthew, Crombie, Jennifer L, Ng, Samuel Y, Kim, Austin I, Jacobson, Caron A, LaCasce, Ann S, Armand, Philippe, Arnason, Jon E, Fisher, David C, Brown, Jennifer R
Published in The lancet oncology (01.10.2021)
Published in The lancet oncology (01.10.2021)
Get full text
Journal Article
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Armand, Philippe, Chen, Yi-Bin, Redd, Robert A., Joyce, Robin M., Bsat, Jad, Jeter, Erin, Merryman, Reid W., Coleman, Kimberly C., Dahi, Parastoo B., Nieto, Yago, LaCasce, Ann S., Fisher, David C., Ng, Samuel Y., Odejide, Oreofe O., Freedman, Arnold S., Kim, Austin I., Crombie, Jennifer L., Jacobson, Caron A., Jacobsen, Eric D., Wong, Jeffrey L., Patel, Sanjay S., Ritz, Jerome, Rodig, Scott J., Shipp, Margaret A., Herrera, Alex F.
Published in Blood (04.07.2019)
Published in Blood (04.07.2019)
Get full text
Journal Article
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
Stephens, Deborah M., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., LaCasce, Ann S., Barr, Paul M., Knopp, Michael V., Hsi, Eric D., Leonard, John P., Kahl, Brad S., Smith, Sonali M., Friedberg, Jonathan W.
Published in Blood (10.10.2019)
Published in Blood (10.10.2019)
Get full text
Journal Article
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial
Neilan, Tomas G, Quinaglia, Thiago, Onoue, Takeshi, Mahmood, Syed S, Drobni, Zsofia D, Gilman, Hannah K, Smith, Amanda, Heemelaar, Julius C, Brahmbhatt, Priya, Ho, Jor Sam, Sama, Supraja, Svoboda, Jakub, Neuberg, Donna S, Abramson, Jeremy S, Hochberg, Ephraim P, Barnes, Jefferey A, Armand, Philippe, Jacobsen, Eric D, Jacobson, Caron A, Kim, Austin I, Soumerai, Jacob D, Han, Yuchi, Friedman, Robb S, Lacasce, Ann S, Ky, Bonnie, Landsburg, Dan, Nasta, Sunita, Kwong, Raymond Y, Jerosch-Herold, Michael, Redd, Robert A, Hua, Lanqi, Januzzi, James L, Asnani, Aarti, Mousavi, Negareh, Scherrer-Crosbie, Marielle
Published in JAMA : the journal of the American Medical Association (08.08.2023)
Published in JAMA : the journal of the American Medical Association (08.08.2023)
Get full text
Journal Article